C-Reactive Protein Pretreatment-Level Evaluation with Histopathological Correlation for Chondrosarcoma Prognosis Assessment-A 15-Year Retrospective Single-Center Study.
Sarah ConsalvoFlorian HinterwimmerMaximilian StephanSebastian BredenUlrich LenzeJan C PeekenRüdiger von Eisenhart-RotheCarolin KnebelPublished in: Diagnostics (Basel, Switzerland) (2024)
A pretreatment CRP value greater than 0.5 mg/dL can be considered a sensitive prognostic and risk factor for distant metastasis for chondrosarcoma patients.